Cargando…

Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres

BACKGROUND: The benefit of implantable defibrillators (ICDs) for primary prevention remains debated. We analysed the implications of prophylactic ICD implantation according to the guidelines in 2 tertiary hospitals, and made a healthcare utilisation inventory. METHODS: The cohort consisted of all co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, T., van Dessel, P. F., Theuns, D. A. M. J., Muskens-Heemskerk, A., van Domburg, R. T., Wilde, A. A., Jordaens, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189312/ https://www.ncbi.nlm.nih.gov/pubmed/21773744 http://dx.doi.org/10.1007/s12471-011-0176-3

Ejemplares similares

Clinical experience with a novel subcutaneous implantable defibrillator system in a single center
por: Dabiri Abkenari, Lara, et al.
Publicado: (2011)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
por: van Barreveld, M., et al.
Publicado: (2017)

Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres
por: Quast, A. F. B. E., et al.
Publicado: (2017)

Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy: An updated meta-analysis and effect on Dutch clinical practice by the Task Force of the Dutch Society of Cardiology
por: Theuns, D. A., et al.
Publicado: (2022)

The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality
por: Theuns, Dominic A.M.J., et al.
Publicado: (2011)

Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohort
por: van Barreveld, M., et al.
Publicado: (2022)

Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis
por: Theuns, Dominic A.M.J., et al.
Publicado: (2010)

Comparison of complications and shocks in paediatric and young transvenous and subcutaneous implantable cardioverter-defibrillator patients
por: Quast, A. B. E., et al.
Publicado: (2018)

Implantable cardioverter defibrillators at the end of life: future perspectives on clinical practice
por: Stoevelaar, R., et al.
Publicado: (2020)

Building centres of expertise according to the Dutch model?
por: Gabreëls, Fons JM, et al.
Publicado: (2010)

A Recalcitrant Electrical Storm and Implantable Defibrillator Exhaustion: Treatment Implications According to and Beyond Guidelines
por: Kontogiannis, Christos, et al.
Publicado: (2019)

Driving restrictions for Dutch patients with an implantable cardioverter defibrillator: Compliance and associated factors
por: Jongejan, N., et al.
Publicado: (2017)

The outcome of treatment in differentiated thyroid cancer according to recommendations in current Dutch and American guidelines
por: van Dijk, Deborah, et al.
Publicado: (2022)

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs
por: Theuns, Dominic A. M. J., et al.
Publicado: (2021)

Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement
por: de Veld, Jolien A, et al.
Publicado: (2023)

Complications related to elective generator replacement of the subcutaneous implantable defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?
por: Wijers, S. C., et al.
Publicado: (2013)

The incidence and impact of implantable cardioverter defibrillator shocks in the last phase of life: An integrated review
por: Stoevelaar, Rik, et al.
Publicado: (2018)

The learning curve associated with the introduction of the subcutaneous implantable defibrillator
por: Knops, Reinoud E., et al.
Publicado: (2016)

Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time
por: von Gunten, Simon, et al.
Publicado: (2016)

Promoting appropriate utilisation of laboratory tests for inflammation at an academic medical centre
por: Bartlett, Kristen J, et al.
Publicado: (2020)

Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study
por: Stoevelaar, Rik, et al.
Publicado: (2020)

Rationale and design of WEBCARE: A randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life
por: Pedersen, Susanne S, et al.
Publicado: (2009)

Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
por: van der Lingen, Anne‐Lotte C.J., et al.
Publicado: (2021)

Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot
por: Opić, Petra, et al.
Publicado: (2012)

Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study
por: Lambiase, Pier D, et al.
Publicado: (2022)

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016)

Advance care planning and end-of-life care in patients with an implantable cardioverter defibrillator: The perspective of relatives
por: Stoevelaar, Rik, et al.
Publicado: (2021)

The development of a decision aid for shared decision making in the Dutch implantable cardioverter defibrillator patient population: A novel approach to patient education
por: Yilmaz, Dilek, et al.
Publicado: (2022)

Adherence to Cardiovascular Prevention Guidelines in an Academic Centre
por: Soltani, Iness, et al.
Publicado: (2023)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Dutch Multidisciplinary Guideline on Dupuytren Disease
por: Kemler, Marius A., et al.
Publicado: (2022)

Biosimilars in the management of chronic inflammatory diseases: The Dutch experience
por: Müskens, Wieland D., et al.
Publicado: (2019)

The risk of ventricular arrhythmias in a Dutch CRT population: CRT-defibrillator versus CRT-pacemaker
por: ter Horst, I. A. H., et al.
Publicado: (2016)

Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices
por: Yalcin, Yunus C, et al.
Publicado: (2020)

Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit
por: Kolk, Maarten Z H, et al.
Publicado: (2023)

Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records
por: Stoevelaar, Rik, et al.
Publicado: (2019)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4tkqo63t7l0q0c1uavuh8dchbu